Risky Business – The Future of Biopharmaceutical Innovation
Saturday, March 2, 2019, 8:30 AM - 6:00 PM
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York, USA
The New York Academy of Sciences
Bio-pharmaceutical companies make some of the biggest and most risky gambles of any industry: each new drug ultimately requires multi-billion-dollar investments. These investments take more than a decade to play out – during which time, profound changes will occur. Internal portfolios wax and wane; competitors’ innovations, regulatory & commercial frameworks reshape the playing field; some therapeutic advancements move the pitch to a new field altogether.
In such an uncertain landscape, companies are constantly rethinking their strategy, and how they can try and take advantage of technical advancements to build innovation models that are fit for the future. With the emergence of open innovation networks, what will be the role for in-house R&D?
Join us again this year to a full-day workshop directed primarily at students and post-docs with an interest in understanding the innovation dynamics of the bio-pharmaceutical industry, and that provides you with a taste of how investment decisions are taken, beating competitors to a lucrative deal, and the challenges the industry faces. Using a competitive board game that has been developed specifically to mimic the pharmaceutical industry, past and present, this workshop will give you the opportunity to take on the role of an executive team of a mid-size company. As a management team, you will develop, execute, alter your strategy in response to your own success and failures, and pounce on the missed opportunities of others. At the end, the winning team will be invited to share their strategy. Major lessons learnt and key questions for the future will be summarized and opened for discussion